# A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant

> **NCT03739502** · PHASE2 · RECRUITING · sponsor: **University of Rochester** · enrollment: 64 (estimated)

## Conditions studied

- AML
- NHL
- Hodgkin Disease
- All
- Myelodysplastic Syndrome

## Interventions

- **DRUG:** Hyperbaric oxygen

## Key facts

- **NCT ID:** NCT03739502
- **Lead sponsor:** University of Rochester
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-02-28
- **Primary completion:** 2027-06
- **Final completion:** 2027-06
- **Target enrollment:** 64 (ESTIMATED)
- **Last updated:** 2025-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03739502

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03739502, "A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03739502. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*